nicotinamide mononucleotide has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Jia, P; Yang, W; Yao, Z | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Cognition Disorders
| Article | Year |
|---|---|
Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Avoidance Learning; Brain; Cognition Disorders; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Memory; Mice, Transgenic; Nicotinamide Mononucleotide; Plaque, Amyloid; Spatial Learning; Synapses | 2017 |